Written Question·Department of Health and Social Care·UIN 3459

Parkinson's Disease: Newcastle-under-Lyme

Tabled: 30 August 2024
Answered: 9 September 2024

Question

Adam Jogee

Labour — Newcastle-under-Lyme

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of procuring Produodopa via the NHS on the treatment of Parkinson's disease in Newcastle-Under Lyme constituency.

Answer

Karin Smyth
The National Institute for Health and Care Excellence (NICE) published guidance recommending foslevodopa–foscarbidopa (Produodopa) for patients with Parkinson’s disease meeting specified clinical criteria, in November 2023. Produodopa is now available to ...
ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 3459) →